[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351913-105":59,"doc-detail-351913-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","peutz-jeghers-syndrome-and-lung-cancer-does-the-risk-meet-the-threshold-for-lung-cancer-screening","Peutz-Jeghers Syndrome and lung cancer: does the risk meet the threshold for lung cancer screening?","","Peutz-Jeghers Syndrome (PJS), driven by germline STK11 pathogenic variants, carries elevated lifetime cancer risks, including lung cancer. This structured narrative review compares lung cancer risk in individuals with PJS to lung cancer risk thresholds used in the general population for age- and smoking-based screening eligibility. Searches of PubMed and Web of Science (1980–2023) included 17 studies. Incidence ranged from 0.8% to 13.3%, with relative risk 2.9–22.9. Cumulative risk in five studies surpassed 5% by age 60 (7–17%).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/peutz-jeghers-syndrome-and-lung-cancer-does-the-risk-meet-the-threshold-for-lung-cancer-screening/351913/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/peutz-jeghers-syndrome-and-lung-cancer-does-the-risk-meet-the-threshold-for-lung-cancer-screening/351913.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What causes Peutz-Jeghers Syndrome, and why is lung cancer risk relevant?","Question",{"text":112,"@type":113},"PJS is caused by germline pathogenic variants in the STK11 gene and is associated with elevated lifetime risks for multiple cancers, including lung cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the review compare PJS lung cancer risk with screening eligibility thresholds?",{"text":117,"@type":113},"It compares reported lung cancer risks in PJS to 5-year, 10-year, and lifetime lung cancer risks in the general population stratified by age and smoking pack-years.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the reported lung cancer risks in PJS suggest about screening with LDCT?",{"text":121,"@type":113},"Reported cumulative risk surpassed 5% by age 60 in studies, and the lifetime risk for PJS is described as similar to current guideline-based thresholds. Individuals with PJS may be candidates for LDCT lung cancer screening.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351913,1790184024,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Familial Cancer (2026) 25:72  \n[https://doi.org/10.1007/s10689-026-00587-8](https://doi.org/10.1007/s10689-026-00587-8)  \nREVIEW  \nPeutz-Jeghers Syndrome and lung cancer: does the risk meet the threshold for lung cancer screening?  \nFaizah Shareef1 · Mounica Konjeti2 · Samir Gupta3 · Jennifer M. Weiss4  \nReceived: 31 March 2026 / Accepted: 15 June 2026 © The Author(s) 2026  \nAbstract  \nPeutz-Jeghers Syndrome (PJS) is caused by germline pathogenic variants in the STK11 gene and is associated with elevated lifetime risks for several cancers, including lung cancer. Currently, no formal recommendations exist for lung cancer screening in PJS. This structured narrative review compares lung cancer risk in PJS with lung cancer risk in individuals currently eligible for screening based on age and smoking history. PubMed and Web of Science were searched from 1/1/1980 to 9/11/2023 using the terms “Peutz-Jeghers Syndrome” AND “Cancer.” Studies reporting lung cancer risk in PJS were included. Reported lung cancer risks were compared to 5-year, 10-year, and lifetime lung cancer risks in the general population based on age and pack-years of smoking. Seventeen studies were included. Across the studies, the incidence of lung cancer ranged from 0.8 to 13.3% . Studies that included lung cancer risk relative to the general population reported a relative risk range of 2.9–22.9. Cumulative risk was reported in 5 studies and surpassed 5% by age 60 (range 7 to 17%) . Guidelines for low-dose CT (LDCT) lung cancer screening for individuals aged 50–80 with a smoking history of at least 20 pack-years are associated with a similar or higher threshold for lung cancer risk. The lifetime lung cancer risk for individuals with PJS is similar to current guideline-based risk thresholds for screening based on age and smoking status. Given their elevated lifetime risk, individuals with PJS may be candidates for LDCT for lung cancer screening and should be formally studied to elucidate the risks, benefits, and optimal implementation in this patient population.  \nKeywords Peutz-Jeghers Syndrome · Lung cancer screening · Cancer risk · Guidelines  \nIntroduction  \nPeutz-Jeghers Syndrome (PJS) is a high-risk cancer predisposition syndrome attributable to pathogenic variants in the STK11 gene, inherited in an autosomal dominant fashion.  \n􀀍 Samir Gupta[s1gupta@health.ucsd.edu](s1gupta@health.ucsd.edu)  \n􀀍 Jennifer M. Weiss [jmw@medicine.wisc.edu](jmw@medicine.wisc.edu)  \n1 Department of Medicine, University of California San Diego, San Diego, CA, USA  \n2 Department of Medicine, University of Vermont Larner College of Medicine, Burlington, VT, USA  \n3 Division of Gastroenterology & Hepatology, University of California San Diego, San Diego, CA, USA  \n4 School of Medicine and Public Health, Division of Gastroenterology & Hepatology, University of Wisconsin, Madison, WI, USA  \nA clinical diagnosis of PJS can be established in a person who has one of the following characteristics: (1) two or more PJS-type hamartomatous polyps of the gastrointestinal tract; (2) any number of PJS-type polyps detected in a patient who has a family history of PJS in close relative(s);(3) mucocutaneous hyperpigmentation of the mouth, lips, nose, eyes, genitalia, or fingers in an individual who has a family history of PJS in close relative(s); (4) any number of PJS-type polyps in an individual who also has characteristic mucocutaneous pigmentation [1] . PJS confers increased lifetime risk for cancer in multiple organs including the small bowel, colon, breast, pancreas, ovaries, uterus, cervix, and lungs, with cumulative lifetime risk for 1 or more cancers as high as 93% without appropriate surveillance [2]. The National Comprehensive Cancer Network (NCCN) has well-established guidelines for small bowel and colon, pancreas, and breast cancer surveillance for patients with PJS [3] . NCCN guidelines also include recommendations for surveillance of the ovaries, cervix, and uterus. Although the NCCN gui","cbCairY70W70tiHP","https://ap.wps.com/l/cbCairY70W70tiHP","pdf",1098231,11,"English","# Abstract\n# Introduction\n## Clinical diagnosis and cancer surveillance context\n## Rationale for evaluating lung cancer screening thresholds\n# Methods\n## Literature search strategy and inclusion criteria\n## Risk reporting and guideline consolidation","[{\"question\":\"What causes Peutz-Jeghers Syndrome, and why is lung cancer risk relevant?\",\"answer\":\"PJS is caused by germline pathogenic variants in the STK11 gene and is associated with elevated lifetime risks for multiple cancers, including lung cancer.\"},{\"question\":\"How does the review compare PJS lung cancer risk with screening eligibility thresholds?\",\"answer\":\"It compares reported lung cancer risks in PJS to 5-year, 10-year, and lifetime lung cancer risks in the general population stratified by age and smoking pack-years.\"},{\"question\":\"What do the reported lung cancer risks in PJS suggest about screening with LDCT?\",\"answer\":\"Reported cumulative risk surpassed 5% by age 60 in studies, and the lifetime risk for PJS is described as similar to current guideline-based thresholds. Individuals with PJS may be candidates for LDCT lung cancer screening.\"}]","Peutz-Jeghers Syndrome and lung cancer: does the risk meet the threshold for lung cancer screening? | PDF",1790096493,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cce541b1e9edb94d0e94f02060499d2.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93511f551289bde61ee0f2ab33b1ca38.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bf1c853104a4473896c0257ea846d9d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c112bd109974caa7122df1d2e77fa80e.webp",980,1301]